Femme Homme
- | Pays :
- Bulgaria
- Ukraine
- Poland
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to evaluate the safety and beneficial effects of NBI-56418 compared to placebo and leuprorelin (an approved endometriosis therapy) over a three month period followed by an additional three months of treatment on NBI-56418.
Critère d'inclusion
- Endometriosis